Jay Andersen

3.6k total citations · 1 hit paper
66 papers, 2.8k citations indexed

About

Jay Andersen is a scholar working on Urology, Rheumatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jay Andersen has authored 66 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Urology, 25 papers in Rheumatology and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jay Andersen's work include Urinary Bladder and Prostate Research (37 papers), Pelvic floor disorders treatments (22 papers) and Urinary Tract Infections Management (14 papers). Jay Andersen is often cited by papers focused on Urinary Bladder and Prostate Research (37 papers), Pelvic floor disorders treatments (22 papers) and Urinary Tract Infections Management (14 papers). Jay Andersen collaborates with scholars based in Denmark, United States and Italy. Jay Andersen's co-authors include Jerry G. Blaivas, Stanton Sl, P Abrams, J. Nørdling, Steen Walter, Paul Abrams, S. L. Stanton, T Hald, H. H. Meyhoff and Peter Klarskov and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Jay Andersen

65 papers receiving 2.6k citations

Hit Papers

The standardisation of te... 1988 2026 2000 2013 1988 250 500 750

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Jay Andersen 1.9k 1.9k 817 672 609 66 2.8k
P. Grise 1.3k 0.7× 1.6k 0.9× 1.2k 1.5× 298 0.4× 714 1.2× 167 2.9k
Tage Hald 1.5k 0.8× 1.2k 0.7× 639 0.8× 495 0.7× 391 0.6× 65 2.2k
X. Gamé 2.0k 1.1× 1.5k 0.8× 942 1.2× 562 0.8× 360 0.6× 264 3.3k
Carlos Arturo Levi D’Ancona 1.4k 0.7× 1.5k 0.8× 796 1.0× 420 0.6× 409 0.7× 89 2.2k
Richard Turner-Warwick 1.8k 1.0× 1.0k 0.5× 1.0k 1.3× 287 0.4× 360 0.6× 58 2.6k
François Haab 3.1k 1.6× 3.7k 2.0× 1.8k 2.2× 838 1.2× 1.0k 1.7× 121 4.9k
Craig V. Comiter 1.8k 1.0× 2.2k 1.2× 1.2k 1.4× 376 0.6× 885 1.5× 111 3.0k
Peter Klarskov 1.6k 0.8× 4.0k 2.1× 3.3k 4.0× 855 1.3× 611 1.0× 68 5.1k
Sandip P. Vasavada 3.0k 1.6× 3.3k 1.8× 1.7k 2.0× 1.2k 1.7× 479 0.8× 127 4.2k
V. Phé 1.1k 0.6× 787 0.4× 888 1.1× 318 0.5× 379 0.6× 171 2.2k

Countries citing papers authored by Jay Andersen

Since Specialization
Citations

This map shows the geographic impact of Jay Andersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay Andersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay Andersen more than expected).

Fields of papers citing papers by Jay Andersen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jay Andersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay Andersen. The network helps show where Jay Andersen may publish in the future.

Co-authorship network of co-authors of Jay Andersen

This figure shows the co-authorship network connecting the top 25 collaborators of Jay Andersen. A scholar is included among the top collaborators of Jay Andersen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jay Andersen. Jay Andersen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Telli, Melinda L., Jennifer K. Litton, J. Thaddeus Beck, et al.. (2024). Neoadjuvant talazoparib in patients with germline BRCA1/2 mutation-positive, early-stage triple-negative breast cancer: exploration of tumor BRCA mutational status. Breast Cancer. 31(5). 886–897. 8 indexed citations
2.
Litton, Jennifer K., J. Thaddeus Beck, Jason M. Jones, et al.. (2023). Neoadjuvant Talazoparib in Patients With Germline BRCA1/2 Mutation-Positive, Early-Stage Triple-Negative Breast Cancer: Results of a Phase II Study. The Oncologist. 28(10). 845–855. 21 indexed citations
3.
Shi, Zhen, Julia Wulfkuhle, Małgorzata Nowicka, et al.. (2021). Functional Mapping of AKT Signaling and Biomarkers of Response from the FAIRLANE Trial of Neoadjuvant Ipatasertib plus Paclitaxel for Triple-Negative Breast Cancer. Clinical Cancer Research. 28(5). 993–1003. 31 indexed citations
4.
Yardley, Denise A., James A. Reeves, Elizabeth Claire Dees, et al.. (2016). Ramucirumab With Eribulin Versus Eribulin in Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracycline and Taxane Therapy: A Multicenter, Randomized, Phase II Study. Clinical Breast Cancer. 16(6). 471–479.e1. 29 indexed citations
5.
Lam, Grace Y., et al.. (2002). Leydig cell tumour – A rare testicular tumour. International Urology and Nephrology. 33(1). 103–105. 12 indexed citations
6.
Navarrete, Remigio Vela, Jay Andersen, Andrzej Borówka, et al.. (2001). The Future of Urology in Europe: An Overview from the European Association of Urology. European Urology. 39(4). 361–368. 9 indexed citations
7.
Navarrete, Remigio Vela, Jay Andersen, Andrzej Borówka, et al.. (2001). El futuro de la urología en europa: una perspectiva desde la asociacion europea de urología. Actas Urológicas Españolas. 25(3). 156–169. 1 indexed citations
8.
Marberger, Michael, Jay Andersen, J. Curtis Nickel, et al.. (2000). Prostate Volume and Serum Prostate–Specific Antigen as Predictors of Acute Urinary Retention. European Urology. 38(5). 563–568. 95 indexed citations
9.
Schäfer, Werner, Teuvo L.J. Tammela, David M. Barrett, et al.. (1999). Continued improvement in pressure-flow parameters in men receiving finasteride for 2 years. Urology. 54(2). 278–283. 22 indexed citations
10.
Nørdling, J., Paul Abrams, Kaname Ameda, et al.. (1998). Outcome measures for research in treatment of adult males with symptoms of lower urinary tract dysfunction. Neurourology and Urodynamics. 17(3). 263–271. 17 indexed citations
11.
Thüroff, J.W., Anders Mattiasson, Jay Andersen, et al.. (1996). The standardization of terminology and assessment of functional characteristics of intestinal urinary reservoirs. British Journal of Urology. 78(4). 516–523. 46 indexed citations
12.
Bernstein, Inge, Jay Andersen, W Fischer-Rasmussen, et al.. (1996). Assessment of lower urinary tract symptoms in women by a self-administered questionnaire: Test-retest reliability. International Urogynecology Journal. 7(1). 37–47. 22 indexed citations
13.
Andersen, Jay, Peter Ekman, Hans Wolf, et al.. (1995). Can finasteride reverse the progress of benign prostatic hyperplasia? a two-year placebo-controlled study. Urology. 46(5). 631–637. 121 indexed citations
14.
Flyger, Henrik, Klaus Brasso, Jesper Sølver Schou, et al.. (1995). Validation of the self‐administered Danish Prostatic Symptom Score (DAN‐PSS‐1) system for use in benign prostatic hyperplasia. British Journal of Urology. 76(4). 451–458. 117 indexed citations
15.
Andersen, Jay. (1991). Benign Prostatic Hyperplasia: Symptoms and Objective Interpretation. European Urology. 20(1). 36–40. 11 indexed citations
16.
Christensen, Steffan Wittrup, et al.. (1991). Transurethral Resection of very large prostates a retrospective study. International Urology and Nephrology. 23(3). 245–250. 1 indexed citations
17.
Rosenberg, Jacob, et al.. (1990). [Urinary retention in connection with postoperative pain treatment with epidural opioids].. PubMed. 152(22). 1574–7. 1 indexed citations
18.
Nielsen, Kurt K., Peter Klarskov, J. Nørdling, Jay Andersen, & H. H. Holm. (1990). The Intraprostatic Spiral. New Treatment for Urinary Retention. British Journal of Urology. 65(5). 500–503. 30 indexed citations
19.
Andersen, Jens Rikardt, Jens Rikardt Andersen, Gunnar Lose, et al.. (1988). Terodiline, Emepronium Bromide or Placebo for Treatment of Female Detrusor Overactivity? A Randomised, Double‐blind, Cross‐over Study. British Journal of Urology. 61(4). 310–313. 23 indexed citations
20.
Andersen, Jay, et al.. (1975). [Mechanical and functional obstructions in the posterior urethra in the male].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 137(50). 2964–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026